Publications

Peer-reviewed publications

Search for Schneider, M. publications on pubmedlogo
 

Schneider M, and Koch M (2003). Chronic pubertal, but not adult chronic cannabinoid treatment impairs sensorimotor gating, recognition memory and the performance in a progressive ratio task in adult rats. Neuropsychopharmacology, 28, 1760-1769.

Schneider M, and Koch M (2005). Deficient social and play behavior in juvenile and adult rats after neonatal cortical lesion. effects of chronic pubertal cannabinoid treatment. Neuropsychopharmacology, 30, 944-57.

Drews E, Schneider M, and Koch M (2005). Effects of the cannabinoid receptor agonist WIN 55,212-2 on operant behavior and locomotor activity in rats. Pharmacol. Biochem. Behav., 80,145-50.

Schneider M, and Koch M (2005). Behavioral and morphological alterations following neonatal excitotoxic lesions of the medial prefrontal cortex in rats. Exp. Neurol. 195, 185-98.

Schneider M, Drews E, and Koch M (2005). Behavioral effects in adult rats of chronic prepubertal treatment with the cannabinoid receptor agonist WIN 55,212-2. Behav. Pharmacol. 16(5-6), 447-453.

Schneider M, and Koch M (2007). Deficient object recognition memory in rats after neonatal mPFC lesion. Effects of peripubertal chronic cannabinoid treatment. Eur. Neuropsychopharmacol., 17, 180-186

Leweke FM, Giuffrida A, Koethe D, Schreiber D, Nolden BM, Neatby MA, Gerth CW, Schneider M, Klosterkötter J, and Piomelli D (2007). Anandamide levels in CSF of patients with first-episode schizophrenia or schizophreniform psychosis. relation to cannabis use. Schiz. Res., 94(1-3), 29-36

Schneider M, Spanagel R, Zhang SJ, Bading H, Klugmann M. (2007). Adeno-associated virus (AAV)-mediated suppression of Ca2+/calmodulin kinase IV activity in the nucleus accumbens modulates emotional behaviour in mice. BMC Neurosci., 8,105

Rodriguez de Fonseca F, Schneider M (2008). The endogenous cannabinoid system and drug addiction. 20 years after the description of the CB1 receptor. Addict. Biol., 13(2),143-146

Schneider M, Spanagel R (2008). Appetitive odor-cue conditioning attenuates the acoustic startle response in rats. Behav. Brain Res., 189, 226–230

Bilbao A, Parkitna JR, Engblom D, Perreau-Lenz S, Sanchis-Segura C, Schneider M, Konopka W, Westphal M, Breen G, Desrivieres S, Klugmann M, Guindalini C, Vallada H, Laranjeira R, Fonseca FR, Schumann G, Schutz G, Spanagel R. (2008) Loss of the Ca2+/calmodulin-dependent protein kinase type IV in dopaminoceptive neurons enhances behavioral effects of cocaine. Proc. Natl. Acad. Sci U S A. 105,17549-54

Schneider M, Schömig E, und Leweke FM (2008) Acute and chronic pubertal cannabinoid administration affect object recognition, social recognition and social behavior in the rat. Addict. Biol. 13, 345-57

Schneider M, Heise V, Spanagel R (2010) Differential involvement of the opioid receptor antagonist naloxone in motivational and hedonic aspects of reward. Behav. Brain Res 208, 466-472

Enkel T, Spanagel R, Vollmayr B, Schneider M (2010) Stress triggers anhedonia in rats bred for learned helplessness. Behav. Brain Res. 209, 183-186

Friemel C, Spanagel R, Schneider M (2010) Reward sensitivity peaks during pubertal development in the rat. Frontiers in Behav. Neurosci. 4,39

Perreau-Lenz S, Sanchis-Segura C, Leonardi-Essmann F, Schneider M and Spanagel R (2010) Development of morphine-induced tolerance and withdrawal. involvement of the clock gene mper2. Eur. Neuropsychopharmacol. 20, 509-17.

Leweke FM, Schneider M (2011) Chronic pubertal cannabinoid treatment as a behavioral model for aspects of schizophrenia. effects of the atypical antipsychotic quetiapine. Int. J. Neuropsychopharmacol. 14, 43–51

Klugmann M, Klippenstein V, Spanagel R, Leweke FM, Schneider M (2011) Cannabinoid exposure in pubertal rats increases spontaneous ethanol consumption and nmda receptor associated protein levels. Int. J. Neuropsychopharmacol. 14, 505–517

Waltereit R, Japs B, Schneider M, Bartsch D (2011) Autistic-like behaviour in TSC2+/- (Eker) rats challenged with kainic acid epilepsy during development. Behav. Genetics. 41, 364-72.

Inta D, Vogt MA, Lima-Ojeda JM, Pfeiffer N, Schneider M, Gass P (2011) Lack of long-term behavioral alterations after early postnatal treatment with tropisetron. Implications for developmental psychobiology. Pharmacol Biochem Behav. 99, 35-41.

Klugmann M, Goepfrich A, Friemel CM, Schneider M (2011) AAV-mediated overexpression of the CB1 receptor in the mPFC of adult rats alters cognitive flexibility, social behavior and emotional reactivity. Frontiers in Behav. Neurosci. 5, 37.

Brand T, Spanagel R, Schneider M (2012) Decreased Reward Sensitivity in Rats from the Fischer344 Strain compared to Wistar Rats is paralleled by Differences in Endocannabinoid Signaling. PLoS ONE 7(2), e31169.

Reviews

Schneider M (2004). Longterm effects of chronic cannabis consumption. Sucht (special issue. Cannabis), 50, 309-319.

Wegener N, Schneider M, Koch M (2008). Das endocannabinoide System des
Gehirns – von der Neurobiologie zur klinischen Relevanz. Neuroforum 04/08

Schneider M (2008). Puberty as a highly vulnerable developmental period for the consequences of cannabis exposure. Addict. Biol., 13(2), 253-263

Schneider M (2009) Cannabis use in pregnancy and early life and its consequences. Animal models. Eur. Arch. Psychiatry Clin. Neurosci. 259(7), 383-93

Hermann D, Fusar-Poli P, Schneider M (2012) Potential protective effects of cannabidiol on neuroanatomical alterations in cannabis users and psychosis: a critical review. Curr. Pharm. Des. in press

Editor: Email
Latest Revision: 2013-02-12
zum Seitenanfang/up